Previously CEO at Fendix, Mark‘s understanding of the wider medtech industry means he is well-placed to accelerate Zetta’s global momentum. Zetta Genomics, a pioneer in large-scale genomic data management, has appointed Mark Bailey as its chief executive officer. Bailey has been brought in to lead Zetta’s next phase of growth. Ludo Chapman, Chair of Zetta Genomics, commented: “We welcome Mark’s […]
Unterägeri, Switzerland _ SmartGene, a leading provider of bioinformatics Software-as-a-Service applications (SaaS Apps), today announced a new collaboration with Illumina, a global leader in DNA sequencing and array-based technologies, to enable broad adoption of Next Generation Sequencing (NGS) for routine analysis in infectious diseases and industrial markets. The scope of the collaboration includes clinical microbiology, food […]
This partnership will use whole human genome sequencing to support actionable characterisation of rare genetic diseases. Oxford Nanopore Technologies (Oxford Nanopore) and Al Jalila Children’s Specialty Hospital (AJCH) today announce a new partnership to investigate the potential utility of nanopore sequencing for children with unresolved rare genetic disorders. AJCH, the first and only dedicated children’s […]
Qingdao, Shenzhen — The 17th Annual Meeting of the International Conference on Genomics (ICG-17), a meeting point for leaders in the emerging field of Genomics to meet and share their experience and insights, is taking place on 5-7 September in Qingdao, China. At ICG-17, MGI introduces its mass production base of its latest miniaturized gene […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company’s acquisition of GRAIL. The company is reviewing the Commission’s order and intends to appeal the decision. The EC decision follows last week’s ruling by US Federal Trade Commission judge in favor of Illumina’s acquisition of GRAIL. “We are disappointed with […]
Wehrheim, Germany – MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has announced the commercial availability of its innovative HotMPS reagents* and sequencing instrument** in Germany as of 9 August 2022. “We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again,” said Dr. […]
genOway to acquire exclusive rights to MilliporeSigma’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Update: September 6, 2022 – Learn about our expanded CRISPR/CAS9 Strategic Alliance here. Burlington, Massachusetts, December 10, 2018 — MilliporeSigma, a leader in genome editing, today […]
The competition nurtures young scientists around the globe QIAGEN-Verogen generously donated a combined instrument and reagents prize package worth up to $ 60,000 Three young forensic scientists have been recognized for work in human identification (HID) and forensics Germantown, Maryland, and Hilden, Germany — QIAGEN today announced the winners of its second Young Investigator Awards (YIA). The […]
BioEcho Life Sciences, a Germany-based biotechnology company supplying the fastest and most sustainable nucleic acid extraction technology, announces the opening of its US subsidiary in Boston, MA. Cologne — The BioEcho subsidiary in the biotechnology hub of Boston is a decisive step in the company’s plan to serve a worldwide growing customer base with best-in-class […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has completed the previously announced merger with 3M’s Food Safety business to create an innovative leader in the food safety sector with a comprehensive product range and a strategic focus on the category’s long-term growth opportunities. The transaction was first announced on December 14, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
